Biotech company that combines the development of machine learning-enabled companion diagnostics with specific therapeutics to personalize the treatment of neuropsychiatric disorders with a focus on depression.
HMNC Brain Health has raised €14M across 1 funding round from 7 investors, most recently a round in Oct 2022. Based in Munich, Germany; active in Healthtech. Data as of 6 Aug 2026.
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-10-21 | Other | €14M |
| Carsten Maschmeyer,Dr. Josef Ackermann,Guntard Gutmann,Hans Kompernaß,Jahr Group,Toni Kroos+1 more |
| View deal → |
